Click here to go to the previous page
Making CRO-Sponsor Partnerships Work: Executive Roundtable
Program Code:
204
Date:
Tuesday, June 25, 2013
Time:
8:00 AM to 9:30 AM
EST
CHAIR
:
Kenneth I. Kaitin,
PhD (SCHSUP), Professor and Director, Center for the Study of Drug Development,
Tufts University School of Medicine, United States
Dr. Kaitin is Professor and Director of the Tufts Center for the Study of Drug Development at Tufts University School of Medicine. Dr. Kaitin is an internationally recognized expert on drug development science and policy.
|
SPEAKER
(S):
Jamie Macdonald, (SPKNON), Chief Executive Officer, INC Research, United States
Jonathan B. Zung,
PhD (SPKNON), Vice President, Head of Global Development Operations,
Bristol-Myers Squibb Company, United States
Jonathan Zung is Vice President of Project Management at Bristol-Myers Squibb in Princeton, NJ.He leads a department of 60+ staff that provides project management support across the R&D organization.Jonathan is also responsible for the leadership & development of exploratory development team leaders
|
Ciaran Murray, (SPKNON), Chief Executive Officer, ICON Plc, Ireland
Peter A. Carberry,
MD,MBA (SPKNON), Senior Vice President, Global Development Operations,
Astellas Pharma Global Development, Inc., United States
Peter completed medical and surgery training at the University of Nairobi, Kenya. He completed postdoc fellowship in Clinical Pharmacology at Univ. of Texas in 1991 and his MBA from Western Michigan University in 2000. He has 18 years of industry experience in Clinical Development.
|
Description
For the past several years, CROs and pharma companies have been forming strategic partnerships designed to improve quality and efficiency in the drug development process. But how strategic are they really? Where are the biggest gains being made? What are some of the pitfalls to avoid? Learn from senior thought leaders in the CRO and pharma industries who have broken new ground in the relationships between sponsors and CROs. These executives will share information on structure, governance, metrics and results.